Regulatory role of vitamin D in T-cell reactivity against myelin peptides in relapsing-remitting multiple sclerosis patients

BMC Neurology

Volumn 12, Issue , 2012, Pages

  Grau López, Laia ^a   Granada, Maria L ^a   Raïch Regué, Dàlia ^b   Naranjo Gómez, Mar ^b   Borràs Serres, Francesc E ^b   Martínez Cáceres, Eva ^b   Ramo Tello, Cristina ^a  

^a HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Multiple sclerosis; T cell proliferation; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; HLA DR15 ANTIGEN; MYELIN; OLIGOCLONAL BAND;

ADULT; ARTICLE; BLOOD SAMPLING; CEREBROSPINAL FLUID ANALYSIS; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DEMOGRAPHY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; FEMALE; HUMAN; IMMUNOREACTIVITY; LYMPHOCYTE PROLIFERATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PEPTIDE ANALYSIS; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; REGULATORY MECHANISM; RELAPSE; SUMMER; T LYMPHOCYTE; VITAMIN BLOOD LEVEL; WINTER;

ADULT; FEMALE; HUMANS; MALE; MULTIPLE SCLEROSIS, RELAPSING-REMITTING; MYELIN PROTEINS; SEASONS; T-LYMPHOCYTES; VITAMIN D;

EID: 84868477587     PISSN: None     EISSN: 14712377     Source Type: Journal    
DOI: 10.1186/1471-2377-12-103     Document Type: Article

References (24)

1. Compston A, Confavreux C, Lassmann H, McDonald I, Miller D, Noseworthy J, et al. McAlpine's Multiple Sclerosis 2006, 982. Philadelphia: Churchill Livingstone Elsevier, Inc.
2. Brown SJ. The role of Vitamin D in multiple sclerosis. Ann Pharmacother 2006, 40:1158-1161. 10.1345/aph.1G513, 16684809.
3. VanAmerongen BM, Dijkstra CD, Lips P, Polman CH. Multiple sclerosis and vitamin D: an update. Eur J Clin Nutr 2004, 58:1095-1109. 10.1038/sj.ejcn.1601952, 15054436.
4. Correale J, Ysrraelit MC, Gaitan MI. Immunomodulatory effects of Vitamin D in multiple sclerosis. Brain 2009, 132:1146-1160. 10.1093/brain/awp033, 19321461.
5. Decallonne B, van Etten E, Overbergh L, Valckx D, Bouillon R, Mathieu C. 1Alpha,25-dihydroxyvitamin D3 restores thymocyte apoptosis sensitivity in non-obese diabetic (NOD) mice through dendritic cells. J Autoimmun 2005, 24:281-289. 10.1016/j.jaut.2005.03.007, 15913954.
6. Raïch-Regué D, Grau-López L, Naranjo-Gómez M, Ramo-Tello C, Pujol-Borrell R, Martínez-Cáceres EM, Borrás FE. Stable antigen-specific T-cell hyporesponsiveness induced by tolerogenic dendritic cells from multiple sclerosis patients. Eur J Immunol 2012, 42:771-782. 10.1002/eji.201141835, 22488365.
7. Munger KL, Levin L, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. J Am Med Assoc 2006, 296:2832-2838.
8. Smolders J, Menheere P, Kessels A, Damoiseaux J, Hupperts R. Association of vitamin D metabolite levels with relapse rate and disability in multiple sclerosis. Mult Scler 2008, 14:1220-1224. 10.1177/1352458508094399, 18653736.
9. Simpson S, Taylor B, Blizzard L, Ponsonby AL, Pittas F, Tremlett H, Dwyer T, Gies P, Van Der Mei I. Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis. Ann Neurol 2010, 68:193-203.
10. Mowry EM, Krupp LB, Milazzo M, Chabas D, Strober JB, Belman AL, McDonald JC, Oksenberg JR, Bacchetti P, Waubant E. Vitamin D status is associated with relapse rate in pediatric-onset multiple sclerosis. Ann Neurol 2010, 67:618-624.
11. Smolders J, Thewissen M, Peelen E, Menheere P, Tervaert JW, Damoiseaux J, Hupperts R. Vitamin D status is positively correlated with regulatory T cell function in patients with multiple sclerosis. PLoS One 2009, 13:6635.
12. Burton JM, Kimball S, Vieth R, Bar-Or A, Dosch HM, Cheung R, et al. A phase I/II dose-escalation trial of vitamin D3 and calcium in multiple sclerosis. Neurology 2010, 74:1852-1859. 10.1212/WNL.0b013e3181e1cec2, 2882221, 20427749.
13. McDonald WI, Compston A, Edan G, Goodkin D, Hartung HP, Lublin FD, et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001, 50:121-127. 10.1002/ana.1032, 11456302.
14. Kurtzke JF. Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983, 33:1444-1452. 10.1212/WNL.33.11.1444, 6685237.
15. Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Pujol-Borrell R, Borràs FE, Martínez-Cáceres E. Myelin peptides in multiple sclerosis. Autoimmun Rev 2009, 8:650-653. 10.1016/j.autrev.2009.02.013, 19393199.
16. Holick MF. Vitamin D, deficiency. N Engl J Med 2007, 357:266-281. 10.1056/NEJMra070553, 17634462.
17. Dawson-Hughes B, Heaney RP, Holick MF, Lips P, Meunier PJ, Vieth R. Estimates of optimal vitamin D status. Osteoporos Int 2005, 16:713-716. 10.1007/s00198-005-1867-7, 15776217.
18. Soilu-Hanninen M, Arias L, Mononen I, Heikkilä A, Viljanen M, Hänninen A. 25-Hydroxyvitamin D levels in serum at the onset of multiple sclerosis. Mult Scler 2005, 11:266-271. 10.1191/1352458505ms1157oa, 15957505.
19. Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 2000, 47:707-717. 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q, 10852536.
20. Smolders J, Damoiseaux J, Menheere P, Hupperts R. Vitamin D as an immune modulator in multiple sclerosis, a review. J Neuroimmunol 2008, 194:7-17. 10.1016/j.jneuroim.2007.11.014, 18177949.
21. Grau-López L, Raïch D, Ramo-Tello C, Naranjo-Gómez M, Dávalos A, Pujol-Borrell R, et al. Specific T-cell proliferation to myelin peptides in relapsing-remitting multiple sclerosis. Eur J Neurol 2011, 18(8):1101-1104. 10.1111/j.1468-1331.2010.03307.x, 21749576.
22. Pedersen LB, Nashold FE, Spach KM, Hayes CE. 1,25-dihydroxyvitamin D3 reverses experimental autoimmune encephalomyelitis by inhibiting chemokine synthesis and monocyte trafficking. J Neurosci Res 2007, 85:2480-2490. 10.1002/jnr.21382, 17600374.
23. Smolders J, Peelen E, Thewissen M, Menheere P, Cohen Tervaert JW, Hupperts R, Damoiseaux J. The relevance of vitamin D receptor gene polymorphisms for vitamin D research in multiple sclerosis. Autoimmun Rev 2009, 8:621-626. 10.1016/j.autrev.2009.02.009, 19393206.
24. Dickinson JL, Perera DI, van der Mei AF, Ponsonby AL, Polanowski AM, Thomson RJ, Taylor BV, McKay JD, Stankovich J, Dwyer T. Past environmental sun exposure and risk of multiple sclerosis: a role for the Cdx-2 Vitamin D receptor variant in this interaction. Mult Scler 2009, 15:563-570. 10.1177/1352458509102459, 19383647.